Skip to main content
Clinical Trials/NCT03096678
NCT03096678
Recruiting
Not Applicable

Morphological and Functional Changes, Risk Stratification and Prognosis of Patients With Compete Left Bundle Branch Block

Chinese Academy of Medical Sciences, Fuwai Hospital1 site in 1 country500 target enrollmentJanuary 1, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bundle-Branch Block, Left
Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Enrollment
500
Locations
1
Primary Endpoint
All-cause death
Status
Recruiting
Last Updated
9 years ago

Overview

Brief Summary

The investigators sought to evaluate the morphological and functional changes, risk stratification and prognosis of patients of participants with compete left bundle branch block (CLBBB).

The conduction of this study was largely due to the increased clinical requirement, which reflected the increased awareness among physicians of heart failure due to asynchronous cardiac function caused by CLBBB. The investigators also aim to figure out the time point or CMR parameters for cardiac resynchronization therapy in patients with CLBBB.

Detailed Description

The effect of cardiac resynchronization therapy (CRT) for heart failure patients was heterogeneous. Candidate selection was important before intervention. The underlying mechanical dyssynchrony of left ventricular bundle branch block was insufficiently descripted. Earlier study of investigators found novel imaging methods such as cardiovascular magnetic resonance imaging including T1 Mapping and feature tracking imaging can provide more detailed information about regional and global LV function in patients. While the role of new cardiac MR imaging techniques in predicting CRT responses, especially in LBBB patients, is still insufficient. Z Chen et al used T1 mapping technique to quantitatively assess the diffuse fibrosis burden of myocardial in heart failure patients. But they found focal fibrosis burden, not diffuse burden, is associated with a poor response to CRT. Other cardiac MR imaging parameters also showed potential predictors of CRT, such as 16 segment time-to-maximum radial wall thickness , scar locations and RV septal lead placement.In this study cardiovascular magnetic resonance imaging (including T1 Mapping combined with feature tracking imaging ) will be applied to follow up LV function in LBBB patients (with or without intervention) in 10 years to find out prognostic predictors and time point or CMR parameters for cardiac resynchronization therapy in patients with CLBBB.

Registry
clinicaltrials.gov
Start Date
January 1, 2010
End Date
December 31, 2025
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Chinese Academy of Medical Sciences, Fuwai Hospital
Responsible Party
Principal Investigator
Principal Investigator

Minjie Lu

Principal Investigator

Chinese Academy of Medical Sciences, Fuwai Hospital

Eligibility Criteria

Inclusion Criteria

  • Subject is 18 years or older and able and willing to consent.
  • The patient should present a complete left bundle branch block (LBBB) with QRS duration of \>120ms
  • The patients should be in NYHA functional class I, II or III.

Exclusion Criteria

  • No informed consent
  • Permanent atrial fibrillation, flutter or tachycardia (\>100 bpm).
  • Right bundle branch block
  • Recent myocardial infarction, within 40 days prior to enrolment.
  • Subject underwent coronary artery bypass graft (CABG) or valve surgery, within 90 days.
  • Implanted with a LV assist device (LVAD), or has reasonable probability (per investigator's discretion) of receiving a LVAD in the next year.
  • Severe aortic stenosis (with a valve area of \<1.0 cm2 or significant valve disease expected to be operated on within study period).
  • Complex and uncorrected congenital heart disease.
  • Claustrophobia or devices

Outcomes

Primary Outcomes

All-cause death

Time Frame: 10 years

Heart Transplantation

Time Frame: 10 years

Cardiovascular death

Time Frame: 10 years

Secondary Outcomes

  • Hospitalization due to heart failure(10 years)
  • Myocardial Infarction(10 years)
  • Stroke(10 years)
  • ICD Implantation(10 years)
  • Pacemaker Implantation(10 years)

Study Sites (1)

Loading locations...

Similar Trials